CEO Joe Payne told investors at the 38th Annual ROTH Conference that the company is refocusing on rare disease programs after gaining approvals for its COVID-19 vaccine in more than 30 countries. Payn ...

BioNTech SE (NASDAQ:BNTX) co-founders Ugur Sahin and Özlem Türeci plan to launch a new independent biotech company focused on next-generation mRNA technologies, the German vaccine developer said on ...

Valneva and Pfizer's three-dose shot targets the outer surface protein A (OspA) of the Borrelia burgdorfii bacteria that ...

Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

One of the largest measles outbreaks the US has seen in decades erupted at Ave Maria University in Florida, but very little ...

BioNTech (NasdaqGS:BNTX) cofounders Ugur Sahin and Özlem Türeci are leaving their roles as CEO and Chief Medical Officer.

DFJ Growth and Northzone lead funding round as startup scales AI tools to detect software vulnerabilities amid rising cyber ...

One of the largest measles outbreaks the US has seen in decades erupted at Ave Maria University in Florida, but very little ...

The co-founders of the Covid-19 vaccine developer BioNTech plan to leave the biotech to start a new mRNA-focused company ...

VetClaw by OpenVet introduces species aware, safety-first clinical workflows designed to help advance the future of ...

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could ...